HEADER OXIDOREDUCTASE 07-MAY-01 1IL0 TITLE X-RAY CRYSTAL STRUCTURE OF THE E170Q MUTANT OF HUMAN L-3-HYDROXYACYL- TITLE 2 COA DEHYDROGENASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HCDH; COMPND 5 EC: 1.1.1.35; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS ABORTIVE TERNARY COMPLEX, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK REVDAT 6 16-AUG-23 1IL0 1 REMARK REVDAT 5 27-OCT-21 1IL0 1 REMARK SEQADV REVDAT 4 04-APR-18 1IL0 1 REMARK REVDAT 3 24-FEB-09 1IL0 1 VERSN REVDAT 2 01-APR-03 1IL0 1 JRNL REVDAT 1 07-NOV-01 1IL0 0 JRNL AUTH J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK JRNL TITL GLUTAMATE 170 OF HUMAN L-3-HYDROXYACYL-COA DEHYDROGENASE IS JRNL TITL 2 REQUIRED FOR PROPER ORIENTATION OF THE CATALYTIC HISTIDINE JRNL TITL 3 AND STRUCTURAL INTEGRITY OF THE ENZYME. JRNL REF J.BIOL.CHEM. V. 276 36718 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11451959 JRNL DOI 10.1074/JBC.M104839200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK REMARK 1 TITL SEQUESTRATION OF THE ACTIVE SITE BY INTERDOMAIN SHIFTING. REMARK 1 TITL 2 CRYSTALLOGRAPHIC AND SPECTROSCOPIC EVIDENCE FOR DISTINCT REMARK 1 TITL 3 CONFORMATIONS OF L-3-HYDROXYACYL-COA DEHYDROGENASE REMARK 1 REF J.BIOL.CHEM. V. 275 27186 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 253077.140 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 35920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1821 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5613 REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 255 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4478 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 196 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.380 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.660 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.910 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.550 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NAD_MOD.PARAM REMARK 3 PARAMETER FILE 4 : CAA.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAD.TOP REMARK 3 TOPOLOGY FILE 4 : CAA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IL0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1000013379. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MAXFLUX REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35973 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.890 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.96 REMARK 200 R MERGE FOR SHELL (I) : 0.26400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1F0Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, N-[2-ACETAMIDO]-2 REMARK 280 -IMINODIACETIC ACID, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.82850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.19750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.85950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.19750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.82850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.85950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE DIMER IS CONTAINED WITHIN THE REMARK 300 ASYMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 70 59.96 -119.90 REMARK 500 VAL A 109 134.43 -37.86 REMARK 500 ALA A 127 171.35 -59.58 REMARK 500 PHE A 205 -116.75 57.83 REMARK 500 ILE A 206 -73.67 -103.74 REMARK 500 ASP A 269 53.80 -178.98 REMARK 500 ALA A 270 -2.24 -53.92 REMARK 500 LYS B 67 4.76 -62.14 REMARK 500 LYS B 68 -30.47 -138.46 REMARK 500 GLU B 72 43.01 -105.14 REMARK 500 ASN B 73 75.43 -176.53 REMARK 500 ALA B 107 59.07 -141.89 REMARK 500 VAL B 109 140.86 -34.20 REMARK 500 PHE B 205 -125.39 65.34 REMARK 500 ILE B 206 -67.53 -99.82 REMARK 500 GLU B 296 135.60 -176.42 REMARK 500 TYR B 301 -161.04 -120.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAA A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAA B 751 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F0Y RELATED DB: PDB REMARK 900 L-3-HYDROXYACYL-COA DEHYDROGENASE COMPLEXED WITH ACETOACETYL-COA REMARK 900 AND NAD+ DBREF 1IL0 A 1 302 UNP Q16836 HCDH_HUMAN 7 308 DBREF 1IL0 B 1 302 UNP Q16836 HCDH_HUMAN 7 308 SEQADV 1IL0 GLN A 170 UNP Q16836 GLU 176 ENGINEERED MUTATION SEQADV 1IL0 GLN B 170 UNP Q16836 GLU 176 ENGINEERED MUTATION SEQRES 1 A 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 A 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 A 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 302 GLN VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 302 LYS TYR LYS SEQRES 1 B 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 B 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 B 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 302 GLN VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 302 LYS TYR LYS HET CAA A 351 54 HET NAD A 350 44 HET CAA B 751 54 HET NAD B 750 44 HETNAM CAA ACETOACETYL-COENZYME A HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 CAA 2(C25 H40 N7 O18 P3 S) FORMUL 4 NAD 2(C21 H27 N7 O14 P2) FORMUL 7 HOH *242(H2 O) HELIX 1 1 GLY A 24 THR A 37 1 14 HELIX 2 2 THR A 47 PHE A 70 1 24 HELIX 3 3 ASN A 73 THR A 87 1 15 HELIX 4 4 ASP A 93 VAL A 98 1 6 HELIX 5 5 HIS A 99 THR A 101 5 3 HELIX 6 6 ASN A 111 ALA A 126 1 16 HELIX 7 7 GLN A 140 ASN A 146 1 7 HELIX 8 8 ARG A 150 ASP A 152 5 3 HELIX 9 9 SER A 178 LEU A 192 1 15 HELIX 10 10 ILE A 206 ARG A 224 1 19 HELIX 11 11 SER A 228 GLY A 241 1 14 HELIX 12 12 GLY A 245 GLY A 254 1 10 HELIX 13 13 GLY A 254 MET A 268 1 15 HELIX 14 14 ASN A 272 GLN A 276 5 5 HELIX 15 15 SER A 278 GLU A 287 1 10 HELIX 16 16 GLY B 24 THR B 37 1 14 HELIX 17 17 THR B 47 PHE B 70 1 24 HELIX 18 18 ASN B 73 SER B 86 1 14 HELIX 19 19 ASP B 93 VAL B 97 5 5 HELIX 20 20 VAL B 97 THR B 101 5 5 HELIX 21 21 ASN B 111 ALA B 126 1 16 HELIX 22 22 GLN B 140 ASN B 146 1 7 HELIX 23 23 ARG B 150 ASP B 152 5 3 HELIX 24 24 SER B 178 LEU B 192 1 15 HELIX 25 25 ILE B 206 ARG B 224 1 19 HELIX 26 26 SER B 228 GLY B 241 1 14 HELIX 27 27 GLY B 245 GLY B 254 1 10 HELIX 28 28 GLY B 254 ASP B 269 1 16 HELIX 29 29 ASN B 272 GLN B 276 5 5 HELIX 30 30 SER B 278 GLU B 287 1 10 HELIX 31 31 LYS B 292 GLY B 295 5 4 SHEET 1 A 8 ILE A 88 SER A 91 0 SHEET 2 A 8 THR A 40 VAL A 44 1 O VAL A 41 N ALA A 89 SHEET 3 A 8 HIS A 17 ILE A 21 1 N VAL A 18 O THR A 40 SHEET 4 A 8 LEU A 103 GLU A 106 1 O LEU A 103 N THR A 19 SHEET 5 A 8 ILE A 131 SER A 134 1 O ILE A 131 N VAL A 104 SHEET 6 A 8 PHE A 154 HIS A 158 1 N ALA A 155 O PHE A 132 SHEET 7 A 8 LEU A 168 ILE A 172 -1 O GLN A 170 N HIS A 158 SHEET 8 A 8 HIS A 195 CYS A 199 1 O HIS A 195 N VAL A 169 SHEET 1 B 8 ILE B 88 SER B 91 0 SHEET 2 B 8 THR B 40 VAL B 44 1 O VAL B 41 N ALA B 89 SHEET 3 B 8 HIS B 17 ILE B 21 1 N VAL B 18 O THR B 40 SHEET 4 B 8 LEU B 103 GLU B 106 1 O LEU B 103 N THR B 19 SHEET 5 B 8 ILE B 131 SER B 134 1 O ILE B 131 N VAL B 104 SHEET 6 B 8 PHE B 154 PHE B 159 1 N ALA B 155 O PHE B 132 SHEET 7 B 8 LEU B 168 ILE B 172 -1 O GLN B 170 N HIS B 158 SHEET 8 B 8 HIS B 195 CYS B 199 1 O HIS B 195 N VAL B 169 CISPEP 1 ASN A 161 PRO A 162 0 -0.60 CISPEP 2 ASN B 161 PRO B 162 0 -0.07 SITE 1 AC1 18 SER A 61 LYS A 68 SER A 137 HIS A 158 SITE 2 AC1 18 PHE A 160 ASN A 161 VAL A 165 ASN A 208 SITE 3 AC1 18 LEU A 211 PRO A 243 MET A 244 LEU A 249 SITE 4 AC1 18 NAD A 350 HOH A 850 HOH A 956 GLY B 239 SITE 5 AC1 18 ALA B 240 HOH B 802 SITE 1 AC2 18 GLY A 239 ALA A 240 SER B 61 LYS B 68 SITE 2 AC2 18 SER B 137 HIS B 158 PHE B 160 ASN B 161 SITE 3 AC2 18 VAL B 165 ASN B 208 LEU B 211 PRO B 243 SITE 4 AC2 18 MET B 244 LEU B 249 NAD B 750 HOH B 804 SITE 5 AC2 18 HOH B1025 HOH B1027 SITE 1 AC3 21 GLY A 23 GLY A 24 LEU A 25 MET A 26 SITE 2 AC3 21 ASP A 45 GLN A 46 ALA A 107 ILE A 108 SITE 3 AC3 21 GLU A 110 LYS A 115 ASN A 135 SER A 137 SITE 4 AC3 21 PHE A 159 ASN A 161 VAL A 253 THR A 257 SITE 5 AC3 21 LYS A 293 CAA A 351 HOH A 809 HOH A 814 SITE 6 AC3 21 HOH A 872 SITE 1 AC4 27 GLY B 24 LEU B 25 MET B 26 ASP B 45 SITE 2 AC4 27 GLN B 46 ALA B 107 ILE B 108 GLU B 110 SITE 3 AC4 27 VAL B 114 LYS B 115 ASN B 135 SER B 137 SITE 4 AC4 27 HIS B 158 PHE B 159 ASN B 161 VAL B 253 SITE 5 AC4 27 THR B 257 LYS B 293 CAA B 751 HOH B 803 SITE 6 AC4 27 HOH B 815 HOH B 816 HOH B 840 HOH B 952 SITE 7 AC4 27 HOH B 998 HOH B1015 HOH B1041 CRYST1 49.657 87.719 158.395 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020138 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011400 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006313 0.00000